Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis
Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis
Active, not recruiting · NCT05938361 · Registry updated 2025-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Active, not recruiting | Not stated | 2025-09-24 | NCT05938361 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Clin4all | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Service de Dermatologie- Hopital Saint Joseph | Paris | France | 1 |